Researchers Find More Evidence That Malaria Drug Could Help Combat Cancer, And That Breaks From Treatment Could Improve Results
Tuesday, Apr. 12th 2011 6:24 AM
Scientists investigating the cancer-fighting properties of artesunate a drug commonly used to treat malaria have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels. The findings, recently published in the International Journal of Cancer, are the result of tests on human cancer cells studied outside the body (in vitro studies) by Dr Wai Liu and Professor Angus Dalgleish at St George’s, University of London.
Related posts:
- Medicaid-funded ADHD Treatment For Children Misses The Mark The enactment of the Patient Protection and Affordable Care Act of 2010 expands Medicare benefits to scores of previously uninsured individuals including many of our nation’s children. While access to treatment is laudable, the quality of such treatment is the subject of an article in the December issue of the Journal of the American Academy […]...
- Owing Largely To Generic Erosion Of Key Agents, The ADHD Drug Market Will Decrease From $5 Billion In 2009 To $4.1 Billion In 2019 Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 […]...
- California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found California Share of Cost, Food Dye Ban Implemented Or Considered By Some Health Authorities After Cancer And Hyperactivity Link Found: After new scientific evidence revealed a possible link between food dyes and childhood cancer and hyperactivity, Australian food authorities are reported to be considering banning food colorings from breakfast cereals and confectionary items. The research […]...
- When Budgets Are Tight, There Are Better Options Than Colonoscopies For Colorectal Cancer Screening [Web First] A critical challenge facing cancer screening programs, particularly those aimed at uninsured people with low incomes, is choosing the screening test that makes the most efficient use of limited budgets. For colorectal cancer screening, there is growing momentum to use colonoscopy, which is an expensive test. In this study, we modeled scenarios to assess whether […]...
- Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism Researchers Develop Mouse Model To Help Find How A Gene Mutation Leads To Autism...
- Results from the 2009 National Survey on Drug Use & Health – Mental Health Findings This report provides information about the prevalence of mental disorders and use of mental health services for youth aged 12 to 17 and adults aged 18 or older. It also looks at mental health, suicidal thoughts and behavior and the co-occurrence of mental illness and substance use. One of the report’s findings is that among the 45.1 million adults aged 18 or older with […]...
- Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night....
- Share of Cost, Study Shows Promise For New Drug To Treat Fragile X The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January issue of Science Translational Medicine. Researchers from Rush University Medical Center helped design the study and are now participating in […]...
- California Share of Cost, Weight Loss And Physical Activity Improve Symptoms Of GERD California Share of Cost, Weight Loss And Physical Activity Improve Symptoms Of GERD: Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers — heartburn, difficulty swallowing, chest pain and acid reflux....
- Asthma And Eczema Sufferers Have A Lower Risk Of Developing A Cancer Men who had a history of asthma or eczema generally had a lower risk of developing cancer, according to a study carried out by researchers at INRS Institut Armand-Frappier, the Research Centre of the Centre hospitalier de l’Université de Montréal, and McGill University…...
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
- Share of Cost, Esophageal Cancer Risk Lower Than Expected For GERD Patients Share of Cost, The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., […]...
Posted on Tuesday, Apr. 12th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »